D. E. Shaw & Co. Inc. Has $33.27 Million Stock Position in Genpact Limited (NYSE:G)

D. E. Shaw & Co. Inc. cut its holdings in Genpact Limited (NYSE:G - Free Report) by 43.2% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 774,572 shares of the business services provider's stock after selling 588,065 shares during the quarter. D. E. Shaw & Co. Inc. owned about 0.44% of Genpact worth $33,268,000 as of its most recent SEC filing.

Several other large investors also recently made changes to their positions in the stock. Coppell Advisory Solutions LLC raised its holdings in Genpact by 529.5% in the 4th quarter. Coppell Advisory Solutions LLC now owns 598 shares of the business services provider's stock valued at $25,000 after acquiring an additional 503 shares during the period. SRH Advisors LLC acquired a new stake in shares of Genpact during the fourth quarter valued at about $26,000. Atlas Capital Advisors Inc. raised its holdings in Genpact by 55.8% in the 4th quarter. Atlas Capital Advisors Inc. now owns 603 shares of the business services provider's stock valued at $26,000 after buying an additional 216 shares during the last quarter. Manchester Capital Management LLC bought a new position in Genpact in the 4th quarter valued at approximately $38,000. Finally, GeoWealth Management LLC lifted its holdings in shares of Genpact by 199.0% during the fourth quarter. GeoWealth Management LLC now owns 876 shares of the business services provider's stock worth $38,000 after purchasing an additional 583 shares during the period. Institutional investors own 96.03% of the company's stock.

Insider Buying and Selling

In other Genpact news, Director Nicholas C. Gangestad acquired 2,000 shares of the company's stock in a transaction that occurred on Tuesday, May 13th. The shares were purchased at an average price of $43.97 per share, for a total transaction of $87,940.00. Following the completion of the purchase, the director now directly owns 2,000 shares in the company, valued at $87,940. The trade was a ∞ increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is accessible through this link. Also, CEO Balkrishan Kalra sold 13,600 shares of the stock in a transaction dated Thursday, March 13th. The stock was sold at an average price of $48.89, for a total transaction of $664,904.00. Following the sale, the chief executive officer now owns 310,246 shares in the company, valued at approximately $15,167,926.94. This trade represents a 4.20% decrease in their position. The disclosure for this sale can be found here. 3.07% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

Several equities research analysts have weighed in on the stock. Robert W. Baird decreased their price target on shares of Genpact from $56.00 to $50.00 and set a "neutral" rating for the company in a research note on Thursday, May 8th. Mizuho upped their price objective on Genpact from $45.00 to $55.00 and gave the company a "neutral" rating in a research note on Monday, February 10th. Jefferies Financial Group upgraded shares of Genpact from a "hold" rating to a "buy" rating and upped their price target for the company from $44.00 to $55.00 in a research note on Tuesday, January 21st. TD Cowen raised shares of Genpact from a "hold" rating to a "buy" rating and upped their target price for the stock from $45.00 to $60.00 in a report on Friday, February 7th. Finally, Needham & Company LLC cut their target price on Genpact from $55.00 to $50.00 and set a "buy" rating for the company in a research note on Thursday, May 8th. Four research analysts have rated the stock with a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of "Hold" and a consensus price target of $50.71.

Genpact Stock Performance

Shares of G traded down $0.46 during midday trading on Wednesday, reaching $43.26. 1,639,746 shares of the stock were exchanged, compared to its average volume of 1,361,321. The business's 50-day moving average price is $48.25 and its 200 day moving average price is $47.05. The company has a debt-to-equity ratio of 0.50, a current ratio of 2.16 and a quick ratio of 1.85. Genpact Limited has a twelve month low of $30.38 and a twelve month high of $56.76. The company has a market capitalization of $7.60 billion, a price-to-earnings ratio of 15.23, a PEG ratio of 1.84 and a beta of 1.02.

Genpact (NYSE:G - Get Free Report) last announced its quarterly earnings results on Wednesday, May 7th. The business services provider reported $0.84 EPS for the quarter, topping the consensus estimate of $0.80 by $0.04. Genpact had a return on equity of 22.50% and a net margin of 10.77%. The business had revenue of $1.21 billion for the quarter, compared to analyst estimates of $1.21 billion. During the same quarter in the previous year, the company earned $0.73 EPS. The company's quarterly revenue was up 7.4% on a year-over-year basis. On average, sell-side analysts expect that Genpact Limited will post 3.21 EPS for the current fiscal year.

About Genpact

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.